ZZ

Zeev Zehavi

Vice President, Venture Investments, Johnson & Johnson Innovation — JJDC

Petah Tikva, Center District

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Education

Lists including Zeev

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

J&
Johnson & Johnson

1999 - 2022

  • Vice President, Venture Investments, Johnson & Johnson Innovation — JJDC

    1999 - 2022

    Focuses on Venture investments in Israel in all three J&J sectors and on Medical Devices in Europe in support of J&J strategic objectives. Works closely with London Innovation Center colleagues, Therapeutic Areas, Business Development and R&D Functional Areas.

CI
Clal Industries

1994 - 1998

  • President, Clal Pharmaceuticals

    1994 - 1998

    Focus on Private equity investments in companies in the field of Generic products, Drug delivery and Chiral chemistry: Pharmaceutical resource inc., Biodar Ltd., FineTech Pharmaceutical.

TP
Teva Pharmaceuticals

1983 - 1993

  • President, Plantex USA

    1988 - 1993

    Managing API sales of bulk chemicals and Oncology hospital products in the US and Canada

  • Area Export Sales Manager for Central America

    1983 - 1988

    Responsible for sales for all Teva Product portfolio in the region including Finished dose generics, API, Consumer products and Sutures.

ID
Israel Defense Forces

1972 - 1978

  • Military Service, Intelligence Forces

    1972 - 1978

    Rank: Major, honorable discharge